A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients

By Ogawa Kohei   Ueno Takao   Kato Ken   Nishitani Hitoshi   Akiyoshi Kohei   Iwasa Satoru   Nakajima Takako   Hamaguchi Tetsuya   Yamada Yasuhide   Hosokawa Ayumu   Sugiyama Toshiro   Shimada Yasuhiro  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1020-1024

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab: In the Treatment of Colorectal Cancer

By Croom Katherine F.   Foster Rachel H.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 187-194

Adis International

Access to resources Recommend Favorite

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1505-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

By Degirmenci M.   Karaca B.   Gorumlu G.   Durusoy R.   Demir Piskin G.   Bozkurt M.   Cirak Y.   Tunali D.   Karabulut B.   Sanli U.   Uslu R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 585-591

Humana Press, Inc

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite